This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.
Minimed 670g systemthe medtronic minimed 670g system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The minimed 670g system includes smartguard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The medtronic minimed 670g system consists of the following devices: minimed 670g insulin pump, the guardian link (3) transmitter, the guardian sensor (3), one-press serter, and the contour next link 2. 4 glucose meter. The system requires a prescription. The guardian sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a finger stick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the guardian sensor (3). Guardian sensor (3)the guardian sensor (3) is intended for use with the minimed 670g system to continuously monitor glucose levels in persons with diabetes. It is intended to be used for detecting trends and tracking patterns in persons aged fourteen years and older, and to be used by the minimed 670g system to automatically adjust basal insulin levels. It is indicated for use as an adjunctive device to complement, not replace, information obtained from standard blood glucose monitoring devices. The sensor is intended for single use and requires a prescription. The guardian sensor (3) is indicated for 7 days of continuous use. One-press serterthe one-press serter is used as an aid for inserting the sensor. It is indicated for single-patient use and it is not intended for multiple-patient use. Guardian link (3) transmitter the guardian link (3) transmitter is intended for use with the minimed 670g system. The guardian link (3) transmitter powers the glucose sensor, collects and calculates sensor data, and wirelessly sends the data to the minimed 670g insulin pump. The transmitter is intended for single-patient multi-use. Contour next link 2. 4 glucose meterthe contour next link 2. 4 wireless blood glucose monitoring system is an over the counter (otc) device utilized by persons with diabetes in home settings for the measurement of glucose in whole blood, and is for single patient use only and should not be shared. The contour next link 2. 4 wireless blood glucose monitoring system is indicated for use with fresh capillary whole blood samples drawn from the fingertip and palm only. The contour next test strips are intended for self-testing by persons with diabetes for the quantitative measurement of glucose in whole blood samples from 20 to 600 mg/dl. The contour next link 2. 4 wireless blood glucose monitoring system is intended to be used to transmit glucose values to the minimed 670g pump and facilitate transfer of information to medtronic carelink software through the use of radio frequency communication. The contour next link 2. 4 wireless blood glucose monitoring system is not intended for the diagnosis of, or screening for, diabetes mellitus. It is not intended for use on neonates.
Device | MiniMed 670G System |
Classification Name | Automated Insulin Dosing Device System, Single Hormonal Control |
Generic Name | Automated Insulin Dosing Device System, Single Hormonal Control |
Applicant | MEDTRONIC MINIMED, INC. |
Date Received | 2016-06-16 |
Decision Date | 2016-09-28 |
Notice Date | 2016-09-28 |
PMA | P160017 |
Supplement | S |
Product Code | OZP |
Docket Number | 16M-1972 |
Advisory Committee | Clinical Chemistry |
Expedited Review | Yes |
Combination Product | No |
Applicant Address | MEDTRONIC MINIMED, INC. 18000 Devonshire Street northridge, CA 91325 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling |
Post-Approval Study: | Show Report Schedule and Study Progress |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P160017 | Original Filing | |
S106 | 2022-11-16 | Special (immediate Track) |
S105 | 2022-11-04 | 30-day Notice |
S104 | ||
S103 | 2022-09-29 | 30-day Notice |
S102 | 2022-09-14 | Special (immediate Track) |
S101 | ||
S100 | 2022-04-01 | 30-day Notice |
S099 | 2022-03-30 | 30-day Notice |
S098 | 2022-03-29 | 30-day Notice |
S097 | ||
S096 | ||
S095 | 2021-11-17 | Special (immediate Track) |
S094 | 2021-09-20 | 30-day Notice |
S093 | ||
S092 | 2021-06-29 | 30-day Notice |
S091 | ||
S090 | 2021-01-27 | Special (immediate Track) |
S089 | ||
S088 | 2020-11-03 | 30-day Notice |
S087 | 2020-08-28 | Real-time Process |
S086 | 2020-08-04 | 30-day Notice |
S085 | 2020-05-26 | 30-day Notice |
S084 | ||
S083 | ||
S082 | 2020-03-30 | 30-day Notice |
S081 | 2020-01-08 | 30-day Notice |
S080 | 2019-12-23 | 30-day Notice |
S079 | 2019-11-29 | 30-day Notice |
S078 | 2019-11-27 | 30-day Notice |
S077 | 2019-11-27 | 30-day Notice |
S076 | ||
S075 | 2019-10-17 | 30-day Notice |
S074 | 2019-10-11 | 30-day Notice |
S073 | 2019-09-30 | 30-day Notice |
S072 | ||
S071 | ||
S070 | 2019-08-21 | 30-day Notice |
S069 | 2019-07-15 | 30-day Notice |
S068 | ||
S067 | 2019-06-19 | 30-day Notice |
S066 | 2019-06-13 | 30-day Notice |
S065 | 2019-05-21 | 30-day Notice |
S064 | 2019-05-17 | 30-day Notice |
S063 | ||
S062 | ||
S061 | ||
S060 | 2019-04-03 | 30-day Notice |
S059 | 2019-04-01 | 30-day Notice |
S058 | 2019-02-25 | 30-day Notice |
S057 | 2019-02-11 | 30-day Notice |
S056 | ||
S055 | 2019-02-01 | 30-day Notice |
S054 | 2019-01-22 | 30-day Notice |
S053 | 2018-11-02 | 30-day Notice |
S052 | 2018-10-15 | 30-day Notice |
S051 | 2018-08-31 | Real-time Process |
S050 | 2018-08-07 | Normal 180 Day Track No User Fee |
S049 | 2018-07-23 | 30-day Notice |
S048 | 2018-07-23 | Normal 180 Day Track |
S047 | 2018-07-09 | 30-day Notice |
S046 | 2018-07-02 | 30-day Notice |
S045 | 2018-06-19 | 30-day Notice |
S044 | 2018-06-07 | Special (immediate Track) |
S043 | 2018-06-04 | 30-day Notice |
S042 | 2018-05-11 | 30-day Notice |
S041 | 2018-03-29 | 30-day Notice |
S040 | 2018-03-26 | 30-day Notice |
S039 | 2018-03-12 | 30-day Notice |
S038 | 2018-02-23 | 30-day Notice |
S037 | 2018-02-09 | Real-time Process |
S036 | 2018-02-07 | 30-day Notice |
S035 | 2018-01-31 | 30-day Notice |
S034 | 2018-01-30 | 30-day Notice |
S033 | 2018-01-29 | 30-day Notice |
S032 | 2018-01-29 | 30-day Notice |
S031 | 2018-01-26 | Panel Track |
S030 | 2018-01-23 | Special (immediate Track) |
S029 | 2017-12-22 | 30-day Notice |
S028 | 2017-11-30 | Real-time Process |
S027 | 2017-11-24 | Normal 180 Day Track No User Fee |
S026 | 2017-11-24 | 30-day Notice |
S025 | ||
S024 | 2017-10-10 | 30-day Notice |
S023 | 2017-10-06 | 30-day Notice |
S022 | ||
S021 | 2017-09-29 | 30-day Notice |
S020 | 2017-09-27 | Normal 180 Day Track |
S019 | 2017-09-14 | 30-day Notice |
S018 | 2017-08-04 | Real-time Process |
S017 | 2017-08-02 | Panel Track |
S016 | 2017-07-21 | Real-time Process |
S015 | ||
S014 | 2017-06-02 | Special (immediate Track) |
S013 | 2017-05-08 | 30-day Notice |
S012 | 2017-04-10 | 30-day Notice |
S011 | 2017-03-31 | 30-day Notice |
S010 | 2017-03-24 | 30-day Notice |
S009 | ||
S008 | 2016-12-30 | Real-time Process |
S007 | 2016-11-28 | 30-day Notice |
S006 | 2016-11-28 | 30-day Notice |
S005 | 2016-11-02 | 30-day Notice |
S004 | 2016-10-27 | Normal 180 Day Track No User Fee |
S003 | 2016-10-26 | Normal 180 Day Track |
S002 | 2016-10-14 | 30-day Notice |
S001 | 2016-10-12 | 30-day Notice |